Published in Cancer Weekly, July 12th, 1999
J. Palou and colleagues from the University Autonoma Barcelona, Spain, evaluated the effectiveness and tolerance of endovesical BCG after pelvic radiation therapy for bladder cancer in patients with recurrence as carcinoma in situ (CIS) and/or high-grade superficial bladder cancer ("Intravesical Bacille Calmette-Guerin in the Treatment of Carcinoma In Situ or High-Grade Superficial Bladder Carcinoma after Radiotherapy for Bladder Carcinoma," BJU International, 1999;83(4):429-431).
"In a prospective study, 13 patients were treated with...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.